Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

144 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Variant allelic frequencies of driver mutations can identify gliomas with potentially false-negative MGMT promoter methylation results.
McCord M, Jamshidi P, Thirunavu V, Santana-Santos L, Vormittag-Nocito E, Dittman D, Parker S, Baczkowski J, Jennings L, Walshon J, McCortney K, Galbraith K, Zhang H, Lukas RV, Stupp R, Dixit K, Kumthekar P, Heimberger AB, Snuderl M, Horbinski C. McCord M, et al. Among authors: jamshidi p. Acta Neuropathol Commun. 2023 Nov 2;11(1):175. doi: 10.1186/s40478-023-01680-0. Acta Neuropathol Commun. 2023. PMID: 37919784 Free PMC article.
Transdifferentiation of metastatic melanoma into cerebellar angiosarcoma.
Kostelecky N, Wadhwani N, Golubovich I, Vormittag-Nocito E, Gao J, Jennings L, Caron M, Jamshidi P, Ahrendsen JT, Castellani R, Brat D, Horbinski C. Kostelecky N, et al. Among authors: jamshidi p. J Neuropathol Exp Neurol. 2024 Dec 1;83(12):1081-1083. doi: 10.1093/jnen/nlae075. J Neuropathol Exp Neurol. 2024. PMID: 38964372 No abstract available.
Diagnostic utility of multimodal advanced molecular testing to classify metastases of unknown primaries: A case of a patient with no known medical history.
Smith H, Jean J, Duckett D, Vormittag-Nocito E, Nezami BG, Jennings LJ, Ahrendsen JT, Yang XJ, Primdahl D, Conway K, Zhong W, Santana-Santos L, Horbinski C, Castellani RJ, Sukhanova M, Jamshidi P. Smith H, et al. Among authors: jamshidi p. J Neuropathol Exp Neurol. 2025 Jan 1;84(1):84-86. doi: 10.1093/jnen/nlae086. J Neuropathol Exp Neurol. 2025. PMID: 39081225 No abstract available.
Dual TERT promoter mutations in an oligodendroglioma, IDH-mutant, 1p/19q co-deleted.
Fernandopulle MS, Cotty-Fattal Z, Smith H, Mejia Bautista M, Ahrendsen JT, Jennings LJ, Santana-Santos L, Sukhanova M, Conway K, Primdahl D, Dixit K, Castellani RJ, Vormittag-Nocito ER, Jamshidi P. Fernandopulle MS, et al. Among authors: jamshidi p. J Neuropathol Exp Neurol. 2025 Jan 11:nlae138. doi: 10.1093/jnen/nlae138. Online ahead of print. J Neuropathol Exp Neurol. 2025. PMID: 39798150 No abstract available.
Post-Surgical Prognosis of Patients with Pineoblastoma: A Systematic Review and Individual Patient Data Analysis with Trends over Time.
Nandoliya KR, Sadagopan NS, Thirunavu V, Houskamp EJ, Karras CL, Chaliparambil RK, Sriram N, Jamshidi P, Raleigh DR, Lukas RV, Magill ST. Nandoliya KR, et al. Among authors: jamshidi p. Cancers (Basel). 2023 Jun 27;15(13):3374. doi: 10.3390/cancers15133374. Cancers (Basel). 2023. PMID: 37444483 Free PMC article. Review.
144 results